Park Ha Biological Technology (BYAH) vs Stepan (SCL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Stepan is the larger company by market cap ($1.39 billion vs $48.5 million), about 28.6 times the size. Stepan pays a dividend yielding 2.57%, while Park Ha Biological Technology does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BYAH | SCL |
|---|---|---|
| Share price | $2.49 | $61.04 |
| Market cap | $48.48M | $1.39B |
| 1-day change | -3.31% | -0.46% |
| YTD return | — | +29.48% |
| 1-year return | — | +28.55% |
| 5-year return | — | -48.69% |
| Forward P/E | — | 16.54 |
| EPS (TTM) | $-37.68 | $-0.12 |
| Dividend yield | 0.00% | 2.57% |
| Annual dividend | $0.00 | $1.57 |
| 52-week high | $188.00 | $68.00 |
| 52-week low | $1.90 | $41.82 |
| Distance from 52-week high | -98.68% | -10.24% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +39.25% |
| Average volume | 457.57K | 140.91K |
| Shares outstanding | 19.46M | 22.71M |
| Employees | — | 2,328 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Package Goods/Cosmetics | Package Goods/Cosmetics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stepan is about 28.6 times larger than Park Ha Biological Technology by market value ($1.39B vs $48.48M).
- Stepan offers a meaningfully higher dividend yield (2.57% vs 0.00%).
About Stepan
SCL stock →Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally. It operates through three segments: Surfactants, Polymers, and Specialty Products.
Consumer Discretionary · Package Goods/Cosmetics · 2,328 employees
BYAH vs SCL FAQ
Which is bigger, Park Ha Biological Technology or Stepan?
Stepan (SCL) is larger, with a market capitalization of $1.39B compared with $48.48M for Park Ha Biological Technology (BYAH).
Which pays a higher dividend, Park Ha Biological Technology or Stepan?
Stepan pays a dividend yielding 2.57%, while Park Ha Biological Technology does not currently pay a regular dividend.
Are Park Ha Biological Technology and Stepan in the same industry?
Yes. Both are classified in the Package Goods/Cosmetics industry within the Consumer Discretionary sector.